Education
About Us
Working with TipRanks
Follow Us
Biosynex SA (DE:0DL)
:0DL
0DL Stock Chart & Stats
Day’s Range― - ―
52-Week Range€1.01 - €5.48
Previous CloseN/A
Volume0.00
Average Volume (3M)56.00
Market Cap
€21.65M
Enterprise ValueN/A
Total Cash (Recent Filing)€132.03M
Total Debt (Recent Filing)€35.31M
Price to Earnings (P/E)―
Beta-0.14
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.32
Shares Outstanding18,748,032
10 Day Avg. Volume69
30 Day Avg. Volume56
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biosynex SA News
0DL FAQ
What was Biosynex SA’s price range in the past 12 months?
Biosynex SA lowest stock price was €1.01 and its highest was €5.47 in the past 12 months.
What is Biosynex SA’s market cap?
Biosynex SA’s market cap is €21.65M.
When is Biosynex SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biosynex SA’s earnings last quarter?
Currently, no data Available
Is Biosynex SA overvalued?
According to Wall Street analysts Biosynex SA’s price is currently Overvalued.
Does Biosynex SA pay dividends?
Biosynex SA does not currently pay dividends.
What is Biosynex SA’s EPS estimate?
Biosynex SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biosynex SA have?
Biosynex SA has 18,748,032 shares outstanding.
What happened to Biosynex SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biosynex SA?
Currently, no hedge funds are holding shares in DE:0DL
Company Description
Biosynex SA
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers a range of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.
Biosynex SA (0DL) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Valbiotis SA
―
Diagnostic Medical Systems
―
Ikonisys SA
―
Euromedis Groupe SA
―
Median Technologies
―